Skip to main content
. 2021 Jul 30;10(15):3408. doi: 10.3390/jcm10153408

Table 1.

Subjects.

Age (Years) Sex (F:M) Platelets
(×109/L)
APTT
(s)
PT-INR D-Dimer
(μg/mL)
ACI 77.0
(60.5–81.8)
26:51 227
(186–269)
29.0
(27.0–32.0)
0.97
(0.94–1.02)
1.1
(0.6–2.1)
Cardioembolic ACI 81.5 *
(71.0–90.0)
5:13 208
(137–254)
31.0 *
(29.8–33.3)
1.01 **
(0.98–1.08)
2.6 *
(0.9–4.6)
Atherosclerotic ACI 72.0
(67.0–78.5)
12:24 241
(185–271)
29.0
(27.0–30.0)
0.96
(0.93–1.00)
1.0
(0.5–2.0)
Lacunar ACI 72.0
(64.3–78.8)
9:14 226
(192–268)
29.0
(26.0–33.0)
0.95
(0.89–0.98)
0.8
(0.5–1.4)
Pulmonary
embolism
66.0
(48.0–74.5)
8:3 241
(146–279)
34.0
(0.3–48.5)
1.11 ***
(1.08–1.37)
5.9 ***
(4.2–17.6)
Deep vein
thrombosis
69.0
(64.8–74.0)
7:5 209
(191–253)
31.0
(28.0–34.5)
1.00
(0.95–1.08)
5.1 *
(0.7–11.0)
TIA 79.0
(70.0–87.0)
3:4 191
(184–321)
28.0
(25.5–29.8)
0.95 **
(0.91–1.05)
0.7
(0.6–0.9)
AMI 79.0
(70.0–87.0)
10:16 190
(154–261)
31.5
(27.0–54.0)
1.02
(0.96–1.23)
1.7
(0.9–3.1)
Syncope 76.0
(36.5–83.3)
4:3 207
(144–255)
30.0
(27.3–30.0)
0.99
(0.93–1.08)
1.8
(1.0–5.1)
DSD 67.5
(54.0–80.0)
15:23 227
(198–277)
28.0
(27.0–32.0)
1.02
(0.93–1.08)
0.9
(0.4–1.6)
Heart
failure
81.0 *
(74.0–86.5)
22:26 177 ***
(131–218)
31.0
(28.0–34.8)
1.11 ***
(1.02–1.24)
2.8 ***
(1.4–5.4)
Anemia/ITP 70.0
(62.0–80.0)
20:10 122 ***
(55–186)
31.0 *
(29.0–39.0)
1.04 **
(1.01–1.07)
0.5 *
(0.4–1.2)
UCS 57.0
(48.0–73.0)
40:35 234
(190–275)
29.0
(27.0–31.8)
0.96
(0.91–1.00)
0.6 **
(0.4–1.5)

Data are expressed as the median (25–75 percentile). ACI, acute cerebral infarction; TIA, transient ischemic attack, AMI, acute myocardial infarction; DSD. Digestive system disease; ITP, idiopathic thrombocytopenic purpura; UCS, indefinite compliant syndrome; *** p < 0.001; ** p < 0.01; * p < 0.05 in comparison to patients with ACI; F, female; M, male; APTT, activated partial thromboplastin time; PT-INR, prothrombin time-international normalized ratio.